FDA regulation of EHRs is UNLIKELY to reduce errors due to

• A. Faulty hardware.
• B. Faulty software.
• C. Design flaws.
• D. Implementation flaws.

Answer: (D)

FDA regulation targets the safety and effectiveness of the EHR as a product, shaping how hardware performs, how software is designed and validated, and how risk is mitigated during development. Errors due to faulty hardware, software defects, or design flaws are addressed through this regulatory framework via quality systems, rigorous testing, validation, and postmarket surveillance. However, errors arising from how the system is implemented in a real-world setting—such as improper configuration, workflow mismatches, inadequate training, data migration mistakes, or integration challenges with other systems—are not typically prevented by FDA oversight. Those implementation issues depend on organizational processes, vendor services, and change-management practices rather than the product’s inherent safety or design. So, implementing a well-regulated EHR is unlikely to reduce errors caused by implementation flaws. To mitigate these, healthcare organizations need strong governance, thorough implementation planning, effective training, and robust change management.